On November 3, 2011, GlaxoSmithKline (“GSK”) announced an agreement in principle with the U.S. government for the largest settlement to date to conclude ongoing government investigations against a pharmaceutical company marketing products in the U.S. The $3 billion settlement against GSK, the world’s fourth largest pharmaceutical company, should be finalized in 2012 and is expected…Read More
GlaxoSmithKline Agrees to a $3 Billion Settlement with the U.S. Government
Posted on November 9, 2011 in Health Law News
Published by: Hall Render